Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Mayr L, Neyazi S, Schwark K, et al. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer cell. 2025. doi:10.1016/j.ccell.2025.02.018 Read more